Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Venetoclax phase III trial disappointment

Lawrence Boise, PhD, Winship Cancer Institute of Emory University, Atlanta, GA, discusses surprising results from a phase III venetoclax combination therapy trial at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.